FMTX - Forma Therapeutics GAAP EPS of -$1.10 misses by $0.11 August, 05 2022 07:18 AM Forma Therapeutics Holdings Inc. Forma Therapeutics press release ( NASDAQ: FMTX ): Q2 GAAP EPS of -$1.10 misses by $0.11 . Cash, cash equivalents and marketable securities were $395.9 million as of June 30 2022. For further details see: Forma Therapeutics GAAP EPS of -$1.10 misses by $0.11